| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/09/1994 | EP0586076A2 Recombinant adenovirus vaccines |
| 03/09/1994 | EP0585390A1 Stealth virus detection in the chronic fatigue syndrome |
| 03/09/1994 | EP0585267A1 Herpesvirus particles and vaccine |
| 03/09/1994 | CN1083527A Recombinant entomopoxvirus |
| 03/08/1994 | US5292653 Equine herpesvirus 1 tk mutants |
| 03/03/1994 | WO1994004678A1 Immunoglobulins devoid of light chains |
| 03/03/1994 | WO1994004662A1 Papillomavirus: biosynthetic process and assays |
| 03/03/1994 | WO1994004661A1 Virus obtainable from human neuroblastoma cells |
| 03/03/1994 | WO1994004660A1 Insect viruses and their uses in protecting plants |
| 03/03/1994 | DE4228787A1 Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate New HIV-1 isolates of subtype vaccine against HIV-1 virus infection of this subtype and methods for their production, use of the HIV-1 virus isolates |
| 03/03/1994 | CA2142902A1 Virus obtainable from human neuroblastoma cells |
| 03/03/1994 | CA2142469A1 Papillomavirus: biosynthetic process and assays |
| 03/03/1994 | CA2141583A1 Insect viruses and their uses in protecting plants |
| 03/02/1994 | EP0584266A1 Recombinant virus expressing carcinoembryonic antigen and methods of use thereof |
| 03/02/1994 | CN1082923A Process for attenuated varicella zoster virus vaccine production |
| 03/01/1994 | US5290686 Insect cell culture of Autographa virus by genetic engineering |
| 02/23/1994 | EP0583998A1 Avirulent antirabies vaccine |
| 02/23/1994 | CN1082606A Genetically engineered attenuated viruses |
| 02/22/1994 | US5288640 Sequences containing the vpu gene and vectors therefore methods of preparation and use |
| 02/22/1994 | US5288630 For preparing specific immune responses against human respiratory syncytial virus |
| 02/22/1994 | US5288616 Orally administering feed containing recombinant nuclear polyhedrosis virus with gene encoding protein |
| 02/22/1994 | CA1327171C Recombinant human cytomegalovirus containing foreign gene and use thereof |
| 02/17/1994 | WO1994003628A1 Recombinant equine herpesviruses |
| 02/17/1994 | WO1994003622A1 D-type retroviral vectors, based on mpmv |
| 02/17/1994 | WO1994003621A1 Vector vaccines of recombinant feline herpesvirus |
| 02/17/1994 | WO1994003596A1 Antisense viruses and antisense-ribozyme viruses |
| 02/17/1994 | WO1994003595A1 Non-shedding live herpesvirus vaccine |
| 02/17/1994 | WO1994003589A2 Hepatitis a virus vaccine |
| 02/17/1994 | WO1994000587A3 Attenuated equine herpesvirus-4 as live vaccine or recombinant vector |
| 02/16/1994 | EP0583142A2 Hepatitis A virus vaccine |
| 02/16/1994 | EP0449897B1 A pure factor i protein and a process for producing said protein |
| 02/15/1994 | US5286640 Entero- or rhinoviruses suitable for use as vaccines |
| 02/15/1994 | US5286639 With DNA coding for newcastle disease virus-derived hemagglutinin renuramindase a non-essential genome region |
| 02/15/1994 | CA1327096C Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses |
| 02/11/1994 | CA2103515A1 Hepatitis a virus vaccine |
| 02/03/1994 | WO1994002596A1 Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
| 02/02/1994 | EP0580737A1 Heterodimeric receptor libraries using phagemids |
| 02/02/1994 | EP0290446B1 Vaccines for human respiratory virus |
| 02/01/1994 | US5283191 Mareks' disease virus vaccine |
| 02/01/1994 | US5283172 Type-C rotavirus cultures and uses therefor |
| 02/01/1994 | US5283170 Sliding stopper with gellable powder between two porous pads; exhausting atmosphere while injecting sample; gelation; fusion |
| 02/01/1994 | US5283034 Stabilization of sterilized surfaces for research and medical use |
| 01/20/1994 | WO1994001573A1 Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 01/20/1994 | WO1994001545A1 Unstabilising viral quasi-species distributions for avoiding resistance phenomena |
| 01/20/1994 | WO1994001134A1 Parenteral immunization against rotavirus |
| 01/20/1994 | CA2116971A1 Parenteral immunization against rotavirus |
| 01/19/1994 | EP0578818A1 Immunotherapy for recurrent hsv infections |
| 01/19/1994 | EP0578726A1 Virus inactivation method and pharmaceutical composition therefor. |
| 01/12/1994 | EP0578328A1 Production of heterodimeric human fertility hormones |
| 01/12/1994 | EP0577894A1 Design, construction and expression of chimeric proteins for development of vaccines and diagnostic reagents |
| 01/06/1994 | WO1994000588A1 Protein based delivery system |
| 01/06/1994 | WO1994000587A2 Attenuated equine herpesvirus-4 as live vaccine or recombinant vector |
| 01/06/1994 | WO1994000585A1 Recombinant baculoviruses containing insect cellular promoter |
| 01/06/1994 | WO1994000562A1 A novel human immunodeficiency virus |
| 01/06/1994 | WO1994000012A1 Nucleic acids and methods of use thereof for controlling viral pathogens |
| 01/06/1994 | WO1993016726A3 Inactivated mycoplasma hyopneumoniae and uses therefor |
| 01/06/1994 | WO1993015207A3 Hepatitis therapeutics |
| 01/06/1994 | CA2138988A1 Recombinant baculoviruses containing insect cellular promoter |
| 01/06/1994 | CA2138414A1 Protein based delivery system |
| 01/05/1994 | DE4222289C1 Verfahren und Mittel zur Instabilisierung von viralen Quasi-Spezies-Verteilungen unter Vermeidung von Resistenzphänomenen Method and means for instabilization of viral quasi-species distributions while avoiding phenomena of resistance |
| 01/04/1994 | US5275934 Method of detecting viral infection in vaccinated animals |
| 01/04/1994 | US5275813 Methods and compositions for vaccinating against feline immunodeficiency virus |
| 12/29/1993 | EP0576092A1 Recombinant Feline herpesvirus vaccine |
| 12/29/1993 | EP0575544A1 Malaria recombinant poxvirus vaccine |
| 12/29/1993 | EP0575491A1 Genetically engineered vaccine strain |
| 12/29/1993 | EP0575485A1 Process for the development of binding mini-proteins |
| 12/28/1993 | US5273876 Comprising the genomic DNA of Towne strain human CMV, a foreign DNA insert and a promoter sequence |
| 12/28/1993 | CA1325611C Heliothis expression systems |
| 12/28/1993 | CA1325610C Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
| 12/23/1993 | WO1993025698A1 Vector particles resistant to inactivation by human serum |
| 12/23/1993 | WO1993025682A2 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 12/23/1993 | WO1993025666A1 Recombinant entomopoxvirus |
| 12/23/1993 | WO1993025665A1 Recombinant herpesvirus of turkeys and uses thereof |
| 12/23/1993 | WO1993025662A2 Replication of hepatitis c virus genome and identification of virus having high infectivity |
| 12/23/1993 | CA2137930A1 Recombinant herpesvirus of turkeys and uses thereof |
| 12/23/1993 | CA2137547A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 12/23/1993 | CA2137449A1 Recombinant entomopoxvirus |
| 12/23/1993 | CA2137361A1 Vector particles resistant to inactivation by human serum |
| 12/22/1993 | CN1079749A Toxins |
| 12/15/1993 | EP0573614A1 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
| 12/15/1993 | EP0573613A1 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
| 12/15/1993 | EP0573611A1 Improved epitode displaying phage |
| 12/15/1993 | EP0573603A1 Inhibitors of human neutrophil elastase and human cathepsin g |
| 12/15/1993 | EP0325635B1 Production of hblv virus in the hsb-2 cell line |
| 12/09/1993 | WO1993024660A1 Method for inhibition of viral morphogenesis |
| 12/09/1993 | WO1993024617A1 Human virus associated with chronic fatigue immune deficiency syndrome (cfids) and assay therefor |
| 12/09/1993 | WO1993024616A1 Process for attenuated varicella zoster virus vaccine production |
| 12/09/1993 | WO1993024528A1 Equine herpesvirus glycoproteins |
| 12/08/1993 | EP0573107A2 Process for attenuated varicella zoster virus vaccine production |
| 12/08/1993 | EP0572978A1 Recombinant insect virus with reduced capacity for host-to-host transmission in the environment and method to produce said virus |
| 12/08/1993 | EP0572401A1 Viral particles having altered host range |
| 12/08/1993 | EP0319542B1 Testing for the human b lymphotropic virus (hblv) |
| 12/07/1993 | US5268292 Infection, cell lysis, purification |
| 12/07/1993 | US5268265 Immunological complex comprising an antigen of Simian Immunodeficiency Virus (SIV) and an antibody against human immunodeficiency virus type 2 (HIV 2), and method and kit for detecting antibodies to HIV-2 reactive with antigens of SIV |
| 12/02/1993 | CA2097389A1 Recombinant insect virus with reduced capacity for host-to-host transmission in the environment and methods to produce said virus |
| 12/01/1993 | EP0571771A2 Method of inactivation of viruses in proteinic preparations |
| 12/01/1993 | EP0571410A1 Herpes simplex virus-1 deletion variants and vaccines thereof |
| 12/01/1993 | EP0323974B1 Method for producing a heterologous protein in insect cells |
| 11/30/1993 | US5266489 Recombinant herpesviruses, in particular for the production of vaccines, process for preparing them, plasmids produced during this process and vaccines obtained |
| 11/30/1993 | US5266317 Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and compositions |